BACKGROUND: We previously found that activation of the glial cell line-derived neurotrophic factor (GDNF) pathway in the ventral tegmental area (VTA) reduces ethanol-drinking behaviors. In this study, we set out to assess the contribution of endogenous GDNF or its receptor GFRalpha1 to the regulation of ethanol-related behaviors. METHODS: GDNF and GFRalpha1 heterozygote mice (HET) and their wild-type littermate controls (WT) were used for the studies. Ethanol-induced hyperlocomotion, sensitization, and conditioned place preference (CPP), as well as ethanol consumption before and after a period of abstinence were evaluated. Blood ethanol concentration (BEC) was also measured. RESULTS: We observed no differences between the GDNF HET and WT mice in the level of locomotor activity or in sensitization to ethanol-induced hyperlocomotion after systemic injection of a nonhypnotic dose of ethanol and in BEC. However, GDNF and GFRalpha1 mice exhibited increased place preference to ethanol as compared with their WT littermates. The levels of voluntary ethanol or quinine consumption were similar in the GDNF HET and WT mice, however, a small but significant increase in saccharin intake was observed in the GDNF HET mice. No changes were detected in voluntary ethanol, saccharin or quinine consumption of GFRalpha1 HET mice as compared with their WT littermates. Interestingly, however, both the GDNF and GFRalpha1 HET mice consumed much larger quantities of ethanol after a period of abstinence from ethanol as compared with their WT littermates. Furthermore, the increase in ethanol consumption after abstinence was found to be specific for ethanol as similar levels of saccharin intake were measured in the GDNF and GFRalpha1 HET and WT mice after abstinence. CONCLUSIONS: Our results suggest that endogenous GDNF negatively regulates the rewarding effect of ethanol and ethanol-drinking behaviors after a period of abstinence.
BACKGROUND: We previously found that activation of the glial cell line-derived neurotrophic factor (GDNF) pathway in the ventral tegmental area (VTA) reduces ethanol-drinking behaviors. In this study, we set out to assess the contribution of endogenous GDNF or its receptor GFRalpha1 to the regulation of ethanol-related behaviors. METHODS:GDNF and GFRalpha1 heterozygote mice (HET) and their wild-type littermate controls (WT) were used for the studies. Ethanol-induced hyperlocomotion, sensitization, and conditioned place preference (CPP), as well as ethanol consumption before and after a period of abstinence were evaluated. Blood ethanol concentration (BEC) was also measured. RESULTS: We observed no differences between the GDNF HET and WT mice in the level of locomotor activity or in sensitization to ethanol-induced hyperlocomotion after systemic injection of a nonhypnotic dose of ethanol and in BEC. However, GDNF and GFRalpha1mice exhibited increased place preference to ethanol as compared with their WT littermates. The levels of voluntary ethanol or quinine consumption were similar in the GDNF HET and WT mice, however, a small but significant increase in saccharin intake was observed in the GDNF HET mice. No changes were detected in voluntary ethanol, saccharin or quinine consumption of GFRalpha1 HET mice as compared with their WT littermates. Interestingly, however, both the GDNF and GFRalpha1 HET mice consumed much larger quantities of ethanol after a period of abstinence from ethanol as compared with their WT littermates. Furthermore, the increase in ethanol consumption after abstinence was found to be specific for ethanol as similar levels of saccharin intake were measured in the GDNF and GFRalpha1 HET and WT mice after abstinence. CONCLUSIONS: Our results suggest that endogenous GDNF negatively regulates the rewarding effect of ethanol and ethanol-drinking behaviors after a period of abstinence.
Authors: J H Kordower; M E Emborg; J Bloch; S Y Ma; Y Chu; L Leventhal; J McBride; E Y Chen; S Palfi; B Z Roitberg; W D Brown; J E Holden; R Pyzalski; M D Taylor; P Carvey; Z Ling; D Trono; P Hantraye; N Déglon; P Aebischer Journal: Science Date: 2000-10-27 Impact factor: 47.728
Authors: R Gerlai; A McNamara; D L Choi-Lundberg; M Armanini; J Ross; L Powell-Braxton; H S Phillips Journal: Eur J Neurosci Date: 2001-10 Impact factor: 3.386
Authors: Yi Ai; William Markesbery; Zhiming Zhang; Richard Grondin; Dennis Elseberry; Greg A Gerhardt; Don M Gash Journal: J Comp Neurol Date: 2003-06-23 Impact factor: 3.215
Authors: Tamara L Doremus-Fitzwater; Hollin M Buck; Kelly Bordner; Laura Richey; Megan E Jones; Terrence Deak Journal: Alcohol Clin Exp Res Date: 2014-08 Impact factor: 3.455
Authors: Mikko Airavaara; Charles L Pickens; Anna L Stern; Kristina A Wihbey; Brandon K Harvey; Jennifer M Bossert; Qing-Rong Liu; Barry J Hoffer; Yavin Shaham Journal: Addict Biol Date: 2010-12-23 Impact factor: 4.280
Authors: Charles L Pickens; Mikko Airavaara; Florence Theberge; Sanya Fanous; Bruce T Hope; Yavin Shaham Journal: Trends Neurosci Date: 2011-07-20 Impact factor: 13.837
Authors: Ida Fredriksson; Sweta Adhikary; Pia Steensland; Leandro F Vendruscolo; Antonello Bonci; Yavin Shaham; Jennifer M Bossert Journal: Neuropsychopharmacology Date: 2016-09-21 Impact factor: 7.853
Authors: Rajani Maiya; Thomas McMahon; Dan Wang; Benjamin Kanter; Dev Gandhi; Holly L Chapman; Jacklyn Miller; Robert O Messing Journal: Neuropharmacology Date: 2016-03-03 Impact factor: 5.250